AUTONOMIX MEDICAL INC (AMIX) Fundamental Analysis & Valuation

NASDAQ:AMIX • US05330T2050

Current stock price

0.3945 USD
-0.01 (-1.99%)
At close:
0.4 USD
+0.01 (+1.39%)
After Hours:

This AMIX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. AMIX Profitability Analysis

1.1 Basic Checks

  • AMIX had negative earnings in the past year.
  • AMIX had a negative operating cash flow in the past year.
AMIX Yearly Net Income VS EBIT VS OCF VS FCFAMIX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 -5M -10M -15M

1.2 Ratios

  • AMIX's Return On Assets of -168.84% is on the low side compared to the rest of the industry. AMIX is outperformed by 88.83% of its industry peers.
  • AMIX has a Return On Equity of -201.38%. This is in the lower half of the industry: AMIX underperforms 76.60% of its industry peers.
Industry RankSector Rank
ROA -168.84%
ROE -201.38%
ROIC N/A
ROA(3y)-170.19%
ROA(5y)N/A
ROE(3y)-217.4%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AMIX Yearly ROA, ROE, ROICAMIX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 -200 -400 -600

1.3 Margins

  • AMIX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AMIX Yearly Profit, Operating, Gross MarginsAMIX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. AMIX Health Analysis

2.1 Basic Checks

  • AMIX has more shares outstanding than it did 1 year ago.
  • There is no outstanding debt for AMIX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AMIX Yearly Shares OutstandingAMIX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 5M 10M 15M 20M
AMIX Yearly Total Debt VS Total AssetsAMIX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 2M 4M 6M 8M

2.2 Solvency

  • AMIX has an Altman-Z score of -11.86. This is a bad value and indicates that AMIX is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -11.86, AMIX is not doing good in the industry: 82.45% of the companies in the same industry are doing better.
  • There is no outstanding debt for AMIX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -11.86
ROIC/WACCN/A
WACCN/A
AMIX Yearly LT Debt VS Equity VS FCFAMIX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 5M -5M

2.3 Liquidity

  • A Current Ratio of 6.18 indicates that AMIX has no problem at all paying its short term obligations.
  • AMIX has a better Current ratio (6.18) than 80.85% of its industry peers.
  • A Quick Ratio of 6.18 indicates that AMIX has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 6.18, AMIX belongs to the top of the industry, outperforming 84.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.18
Quick Ratio 6.18
AMIX Yearly Current Assets VS Current LiabilitesAMIX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 2M 4M 6M 8M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. AMIX Growth Analysis

3.1 Past

  • AMIX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 68.27%, which is quite impressive.
EPS 1Y (TTM)68.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.34%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, AMIX will show a very negative growth in Earnings Per Share. The EPS will decrease by -12.65% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-78.87%
EPS Next 2Y-6.98%
EPS Next 3Y-12.65%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AMIX Yearly Revenue VS EstimatesAMIX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 200K 400K 600K 800K
AMIX Yearly EPS VS EstimatesAMIX Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 -0.5 -1 -1.5 -2 -2.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. AMIX Valuation Analysis

4.1 Price/Earnings Ratio

  • AMIX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year AMIX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AMIX Price Earnings VS Forward Price EarningsAMIX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMIX Per share dataAMIX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3 -4

4.3 Compensation for Growth

  • AMIX's earnings are expected to decrease with -12.65% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.98%
EPS Next 3Y-12.65%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AMIX Dividend Analysis

5.1 Amount

  • AMIX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AMIX Fundamentals: All Metrics, Ratios and Statistics

AUTONOMIX MEDICAL INC

NASDAQ:AMIX (4/2/2026, 8:07:54 PM)

After market: 0.4 +0.01 (+1.39%)

0.3945

-0.01 (-1.99%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-11
Earnings (Next)N/A
Inst Owners2.51%
Inst Owner Change-0.01%
Ins Owners3.01%
Ins Owner Change0%
Market Cap4.50M
Revenue(TTM)N/A
Net Income(TTM)-17.24M
Analysts85
Price Target5.2 (1218.12%)
Short Float %1.84%
Short Ratio0.96
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)8.62%
Min EPS beat(2)-22.44%
Max EPS beat(2)39.67%
EPS beat(4)1
Avg EPS beat(4)-8.37%
Min EPS beat(4)-43.68%
Max EPS beat(4)39.67%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-22.73%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.21%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.79%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.53
P/tB 0.53
EV/EBITDA N/A
EPS(TTM)-4.62
EYN/A
EPS(NY)-1.66
Fwd EYN/A
FCF(TTM)-1.04
FCFYN/A
OCF(TTM)-1.04
OCFYN/A
SpS0
BVpS0.75
TBVpS0.75
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -168.84%
ROE -201.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-170.19%
ROA(5y)N/A
ROE(3y)-217.4%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 19.3%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.18
Quick Ratio 6.18
Altman-Z -11.86
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)68.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.34%
EPS Next Y-78.87%
EPS Next 2Y-6.98%
EPS Next 3Y-12.65%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-63.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-24.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-24.22%
OCF growth 3YN/A
OCF growth 5YN/A

AUTONOMIX MEDICAL INC / AMIX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for AUTONOMIX MEDICAL INC?

ChartMill assigns a fundamental rating of 2 / 10 to AMIX.


Can you provide the valuation status for AUTONOMIX MEDICAL INC?

ChartMill assigns a valuation rating of 0 / 10 to AUTONOMIX MEDICAL INC (AMIX). This can be considered as Overvalued.


Can you provide the profitability details for AUTONOMIX MEDICAL INC?

AUTONOMIX MEDICAL INC (AMIX) has a profitability rating of 0 / 10.


What is the expected EPS growth for AUTONOMIX MEDICAL INC (AMIX) stock?

The Earnings per Share (EPS) of AUTONOMIX MEDICAL INC (AMIX) is expected to decline by -78.87% in the next year.